Filters: Author is Lim, Joseph K [Clear All Filters]
"Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status." Open forum infectious diseases 4, no. 2 (2017): ofx012. Abstract
"Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection." Journal of substance abuse treatment 68 (2016): 62-7. Abstract
"Use of Transient Elastography in Patients with HIV-HCV Co-infection: A Systematic Review and Meta-analysis." Journal of gastroenterology and hepatology (2016). Abstract
"Isolated Hepatitis B Core Antibody is Associated with Advanced Hepatic Fibrosis in HIV/HCV Infection but not in HIV infection alone." Journal of acquired immune deficiency syndromes (1999) (2016).
"Disparities in Hepatitis C Testing in U.S. Veterans Born 1945-1965." Journal of hepatology (2016). Abstract
"Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients." Open forum infectious diseases 2, no. 3 (2015): ofv109. Abstract
"Prevalence of Hepatitis Delta Infection in the United States: NHANES 1999-2012." Hepatology (Baltimore, Md.) (2015).
"HCV Council - Critical Appraisal of Data: Recommendations for Clinical Practice in a Rapidly Evolving Therapeutic Landscape." Liver international : official journal of the International Association for the Study of the Liver (2015). Abstract
"Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum." The International journal on drug policy (2015). Abstract
"Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET." Journal of hepatology 62, no. 2 (2015): 286-93. Abstract
"Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade." PloS one 10, no. 8 (2015): e0135645. Abstract
"Reply to Marcellin et al." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 59, no. 8 (2014): 1192-3.
"Hepatic Decompensation in Antiretroviral-Treated Patients Co-Infected With HIV and Hepatitis C Virus Compared With Hepatitis C Virus-Monoinfected Patients: A Cohort Study." Annals of internal medicine 160, no. 6 (2014). Abstract
"Reply to: High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/HCV-coinfected patients: a gender analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2014).
"Relationship Between Alcohol Use Categories and Noninvasive Markers of Advanced Hepatic Fibrosis in HIV-Infected, Chronic Hepatitis C Virus-Infected, and Uninfected Patients." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2014). Abstract
"Antiretroviral Therapy Reduces the Rate of Hepatic Decompensation among HIV- and Hepatitis C Virus-Coinfected Veterans." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2013). Abstract
"Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial." The Lancet infectious diseases 12, no. 9 (2012): 671-7. Abstract
"Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance program: implications for program replication." The American journal of drug and alcohol abuse 38, no. 3 (2012): 206-12. Abstract
"FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patients." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20, no. 12 (2011): 2512-7. Abstract
